SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 217,345 shares at $27.39 ($6.0M) on 2022-11-29, disclosed to the SEC on 2022-11-30.
Open-market sale of $6.0M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.45 | 37,104 | $1.0M | 17.1% |
| 2 | $27.45 | 37,104 | $1.0M | 17.1% |
| 3 | $28.02 | 885 | $25K | 0.4% |
| 4 | $27.39 | 71,126 | $1.9M | 32.7% |
| 5 | $27.39 | 71,126 | $1.9M | 32.7% |
| Total | $27.41 avg | 217,345 |
| $6.0M |
| 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |